Back
Design Therapeutics, Inc. Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
72
DSGN
Design Therapeutics, Inc.
Last Price:
$9.82
Seasonality Move:
-15.75%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing selling pressure, which indicates risk of future bearish movement.
Design Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.43 | Buy |
| 20-day SMA: | 8.37 | Buy |
| 50-day SMA: | 7.21 | Buy |
| 200-day SMA: | 5.1 | Buy |
| 8-day EMA: | 9.31 | Buy |
| 20-day EMA: | 8.52 | Buy |
| 50-day EMA: | 7.46 | Buy |
| 200-day EMA: | 5.74 | Buy |
Design Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 71.02 | Buy |
| Chaikin Money Flow: | -219512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.9 - 9.12) | Buy |
| Bollinger Bands (100): | (4.71 - 7.65) | Buy |
Design Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics, Inc. Stock
Is Design Therapeutics, Inc. Stock a Buy?
-
Design Therapeutics, Inc. share price is 9.77 while DSGN 8-day simple moving average is 9.43, which is a Buy signal.
-
The stock price of DSGN is 9.77 while Design Therapeutics, Inc. 20-day SMA is 8.37, which makes it a Buy.
-
Design Therapeutics, Inc. 50-day simple moving average is 7.21 while DSGN share price is 9.77, making it a Buy technically.
-
DSGN stock price is 9.77 and Design Therapeutics, Inc. 200-day simple moving average is 5.10, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Buy
72
Design Therapeutics, Inc. (DSGN)
is a Buy
Is Design Therapeutics, Inc. a Buy or a Sell?
-
Design Therapeutics, Inc. stock is rated a BuyThe current Design Therapeutics, Inc. [DSGN] share price is $9.77. The Score for DSGN is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Design Therapeutics, Inc. Stock Info
Market Cap:
556.5M
Price in USD:
9.77
Share Volume:
296.6K
Design Therapeutics, Inc. 52-Week Range
52-Week High:
10.31
52-Week Low:
2.60
Buy
72
Design Therapeutics, Inc. (DSGN)
is a Buy
Design Therapeutics, Inc. Share Price Forecast
-
What is the Design Therapeutics, Inc. stock price today?The Design Therapeutics, Inc. stock price is 9.77 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics, Inc. is not overvalued.
Is Design Therapeutics, Inc. Stock a Buy?
-
Design Therapeutics, Inc. share price is 9.77 while DSGN 8-day exponential moving average is 9.31, which is a Buy signal.
-
The stock price of DSGN is 9.77 while Design Therapeutics, Inc. 20-day EMA is 8.52, which makes it a Buy.
-
Design Therapeutics, Inc. 50-day exponential moving average is 7.46 while DSGN share price is 9.77, making it a Buy technically.
-
DSGN stock price is 9.77 and Design Therapeutics, Inc. 200-day simple moving average is 5.74, creating a Buy signal.
Fundamental Analysis of Design Therapeutics, Inc.
Is Design Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Design Therapeutics, Inc.
Should I short Design Therapeutics, Inc. stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is 0.78, suggesting Design Therapeutics, Inc. is a Buy
-
Design Therapeutics, Inc. Relative Strength Index (RSI) is 71.02, which suggest Design Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Design Therapeutics, Inc. is (6.9 - 9.12), which suggest Design Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Design Therapeutics, Inc. is (4.71 - 7.65), which suggest Design Therapeutics, Inc. is a Buy
* Design Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.